Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial-Reference-Cited by-同舟云学术

Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial

Published:2012 Issue:2 Volume:27 Page:200
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Min Ju-Hong¹,Hong Yoon-Ho²,Sung Jung-Joon³,Kim Sung-Min³,Lee Jung Bok⁴,Lee Kwang-Woo³

Affiliation:

1. Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

2. Department of Neurology, Seoul Metropolitan Goverment Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

3. Department of Neurology, Clinical Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

4. Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3346/jkms.2012.27.2.200

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Roles of Bile Acids and TGR5 in the Central Nervous System: Molecular Functions and Therapeutic Implications;International Journal of Molecular Sciences;2024-08-27

2. Sodium Phenylbutyrate and Tauroursodeoxycholic Acid: A Story of Hope Turned to Disappointment in Amyotrophic Lateral Sclerosis Treatment;Clinical Drug Investigation;2024-06-23

3. Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease;2024-01-21

4. Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to Expect;Clinical Drug Investigation;2023-11-16

5. Factors impacting trial participation in people with motor neuron disease;Journal of Neurology;2023-10-03